The metabolomics analysis of plasma revealed that a panel of 17 potential biomarkers could be useful for distinguishing between BD and MDD patients, with Cer(d18:0/20:4) emerging as the strongest predictor for BD classification. The gene discussed is CBLN1; the disease is major depressive disorder.